South Korea
· Delayed Price · Currency is KRW OSTEONIC Statistics
Total Valuation
OSTEONIC has a market cap or net worth of KRW 120.79 billion. The enterprise value is 122.91 billion.
| Market Cap | 120.79B |
| Enterprise Value | 122.91B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
OSTEONIC has 19.80 million shares outstanding. The number of shares has increased by 14.92% in one year.
| Shares Outstanding | 19.80M |
| Shares Change (YoY) | +14.92% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 19.96% |
| Owned by Institutions (%) | 3.95% |
| Float | 15.79M |
Valuation Ratios
The trailing PE ratio is 20.66.
| PE Ratio | 20.66 |
| Forward PE | n/a |
| PS Ratio | 3.88 |
| PB Ratio | 2.25 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.24, with an EV/FCF ratio of -27.76.
| EV / Earnings | 20.90 |
| EV / Sales | 3.95 |
| EV / EBITDA | 13.24 |
| EV / EBIT | 19.73 |
| EV / FCF | -27.76 |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.30.
| Current Ratio | 3.11 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | 1.73 |
| Debt / FCF | -3.62 |
| Interest Coverage | 9.80 |
Financial Efficiency
Return on equity (ROE) is 11.70% and return on invested capital (ROIC) is 6.14%.
| Return on Equity (ROE) | 11.70% |
| Return on Assets (ROA) | 5.40% |
| Return on Capital (ROIC) | 6.14% |
| Revenue Per Employee | 217.66M |
| Profits Per Employee | 41.13M |
| Employee Count | 143 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.19% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +33.19% |
| 50-Day Moving Average | 5,370.50 |
| 200-Day Moving Average | 5,025.75 |
| Relative Strength Index (RSI) | 59.42 |
| Average Volume (20 Days) | 480,408 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSTEONIC had revenue of KRW 31.12 billion and earned 5.88 billion in profits. Earnings per share was 295.19.
| Revenue | 31.12B |
| Gross Profit | 14.87B |
| Operating Income | 6.23B |
| Pretax Income | 4.53B |
| Net Income | 5.88B |
| EBITDA | 9.28B |
| EBIT | 6.23B |
| Earnings Per Share (EPS) | 295.19 |
Balance Sheet
The company has 13.89 billion in cash and 16.01 billion in debt, giving a net cash position of -2.12 billion or -107.13 per share.
| Cash & Cash Equivalents | 13.89B |
| Total Debt | 16.01B |
| Net Cash | -2.12B |
| Net Cash Per Share | -107.13 |
| Equity (Book Value) | 53.65B |
| Book Value Per Share | 2,709.23 |
| Working Capital | 29.77B |
Cash Flow
In the last 12 months, operating cash flow was 3.96 billion and capital expenditures -8.38 billion, giving a free cash flow of -4.43 billion.
| Operating Cash Flow | 3.96B |
| Capital Expenditures | -8.38B |
| Free Cash Flow | -4.43B |
| FCF Per Share | -223.56 |
Margins
Gross margin is 47.78%, with operating and profit margins of 20.01% and 18.90%.
| Gross Margin | 47.78% |
| Operating Margin | 20.01% |
| Pretax Margin | 14.55% |
| Profit Margin | 18.90% |
| EBITDA Margin | 29.82% |
| EBIT Margin | 20.01% |
| FCF Margin | -14.22% |
Dividends & Yields
OSTEONIC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.92% |
| Shareholder Yield | -14.92% |
| Earnings Yield | 4.84% |
| FCF Yield | -3.66% |
Stock Splits
The last stock split was on June 24, 2020. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 24, 2020 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
OSTEONIC has an Altman Z-Score of 3.18.
| Altman Z-Score | 3.18 |
| Piotroski F-Score | n/a |